FDA warns of bowel obstruction risk linked to GSK's Rotarix

09/22/2010 | Reuters

The FDA warned that Rotarix, a rotavirus vaccine by GlaxoSmithKline, might cause an increased risk of a bowel obstruction. The warning is based on preliminary data from a Mexican study involving infants. "Although the results are preliminary and will require further evaluation, FDA approved revised labeling to inform health care providers of this finding," according to the agency's website.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA